Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Vietnam Medi-Pharm Exp...Vietnam Medi-Pharm Expo
Not Confirmed
Not Confirmed
31 July-02 August, 2025
Not Confirmed
Not Confirmed
12-14 August, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Vietnam Medi-Pharm Exp...Vietnam Medi-Pharm Expo
Industry Trade Show
Not Confirmed
31 July-02 August, 2025
Industry Trade Show
Not Confirmed
12-14 August, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
25 Jul 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/chinese-antibody-developer-leads-biolabs-hits-hong-kong-stock-exchange-189m-ipo
31 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/breakthrough-clinical-data-for-lbl-024-in-first-line-treatment-of-advanced-ep-nec-unveiled-at-2025-asco-oral-session-302466588.html
22 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fda-granted-orphan-drug-designation-of-lbl-024-an-anti-pd-l14-1bb-bispecific-antibody-developed-by-leads-biolabs-for-treatment-of-neuroendocrine-cancer-302314012.html
07 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aditum-bio-and-leads-biolabs-announce-the-formation-of-oblenio-bio-to-develop-a-tri-specific-t-cell-engager-for-autoimmune-disorders-302297928.html
06 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/leads-biolabs-receives-orphan-drug-designation-from-the-us-fda-for-lbl-034-a-uniquely-designed-highly-differentiated-anti-gprc5dcd3-bispecific-antibody-for-the-treatment-of-multiple-myeloma-302297287.html
17 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/leads-biolabs-unveils-preclinical-data-on-lbl-047-a-novel-first-in-class-long-acting-tacianti-bdca2-bispecific-antibody-fusion-protein-in-an-oral-presentation-at-eular-2024-congress-302173974.html
ABOUT THIS PAGE